Skip to main content
Tech.euFundingExplorerBeta

Enifer

Sustainably produced protein is one of the most important aims for the future food production.

Enifer has raised €60M across 4 funding rounds from 7 investors, most recently a Series B round in May 2024. Based in Espoo, Finland; founded 2019; active in Healthtech. Data as of 28 Oct 2026.

Espoo, FinlandFounded 2019www.eniferbio.fi ↗
Total raised
€60M
€60,000,000
Funding rounds
4
Investors
7
distinct backers
Active since
2020-11
latest 2024-05

Funding by year

EUR raised per year
Enifer — funding by year — interactive chart.
Data table
Enifer — funding by year
2020€1.0M
2023€11M
2024€48M

Signals

High confidence
Raise-next likelihood37
base rate 48% for Series B
  • ▼ Past typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood13
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 4 rounds raised
  • ▲ 7y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector or country

Global coverage: FundingData